21.07.2025 • NewsHarkeHarke GroupThorsten Harke

Harke Acquires Swedish Vendico

Harke Group, a high-performance chemicals and plastics distributor based in Mülheim an der Ruhr, Germany, acquired the Swedish Vendico Group, comprising Vendico Chemical, Inventicon, and Omni International.

Thorsten Harke
Thorsten Harke, President of Harke Group
© Harke Group

Vendico Group represents several dozen leading manufacturers of chemical raw materials in the Personal Care, Home Care, and I&I sectors, as well as other applications. It has a broad range of chemicals that are directed towards many branches of the Nordic chemical industry, with a strong foothold on companies working with surface active applications.

Thorsten Harke, President of Harke Group commented: “With the acquisition of Vendico Group, we further strengthen our presence in the Nordic chemical distribution market. Vendico Group fits perfectly to Harke Group. Not only concerning the regions it covers — Sweden, Denmark, Norway, Finland, Iceland and the Baltic region. But also from its product range and the principals it represents, of which many had been cooperating with Harke Group before already. By combining the two company groups we can now offer an even better coverage and service to our customers and principals throughout Europe and Asia.”

Company

Logo:

Harke Group GmbH

Xantener Str. 1
45479 Mülheim
Germany

Company contact







Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.